Safety of different amphotericin B formulations among AIDS patients with invasive fungal disease: a retrospective observational study.
We conducted a retrospective, observational study among acquired immune deficiency syndrome (AIDS) patients with cryptococcal meningitis or talaromycosis to assess AmB formulations-related adverse events (AEs). Total 205...
Read More